-
1
Proliferating CLL cells express high levels of CXCR4 and CD5
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
2
-
3
High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
4
Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patients
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
5
-
6
Inflammatory pathways and anti‐inflammatory therapies in sickle cell disease
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
7
-
8
Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
9
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
10
Interferon gamma‐mediated prevention of tumor progression in a mouse model of multiple myeloma
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
11
Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
12
Models for the marrow: A comprehensive review of AI‐based cell classification methods and malignancy detection in bone marrow aspirate smears
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
13
Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
14
Cerebral hemodynamics and oxygen metabolism in patients with milder and severe forms of sickle cell disease and thalassemia
Published 2024-12-01“…HemaSphere…”
Get full text
Article -
15
-
16
Expression profile of Bcl‐2 family proteins in newly diagnosed multiple myeloma patients
Published 2024-12-01“…HemaSphere…”
Get full text
Article